Effect of aging on airway remodeling and muscarinic receptors in a murine acute asthma model

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 1393-1403

  Kang, Ji Young ^a   Lee, Sook Young ^a   Rhee, Chin Kook ^a   Kim, Seung Joon ^a   Kwon, Soon Seog ^a   Kim, Young Kyoon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Aging; Airway remodeling; Asthma; Muscarinic receptor

Indexed keywords

COLLAGEN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; OVALBUMIN;

AGE DISTRIBUTION; AGING; AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL COUNT; CELL LEVEL; COLLAGEN METABOLISM; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; HELPER CELL; HISTOLOGY; INFLAMMATORY CELL; LUNG ALVEOLUS WALL; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PATHOGENESIS; PERIODIC ACID SCHIFF STAIN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS;

AGING; AIRWAY REMODELING; ASTHMA; MUSCARINIC RECEPTOR;

AGING; AIRWAY REMODELING; ANIMALS; ASTHMA; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOCHEMISTRY; INTERLEUKINS; LUNG; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC;

EID: 84886906677     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S50496     Document Type: Article

References (35)

1. Vignola AM, Scichilone N, Bousquet J, Bonsignore G, Bellia V. Aging and asthma: pathophysiological mechanisms. Allergy. 2003;58(3): 165-175.
2. Ide K, Hayakawa H, Yagi T, etal. Decreased expression of Th2 type cytokine mRNA contributes to the lack of allergic bronchial inflammation in aged rats. J Immunol. 1999;163(1):396-402.
3. Gelfand EW, Joetham A, Cui ZH, etal. Induction and maintenance of airway responsiveness to allergen challenge are determined at the age of initial sensitization. J Immunol. 2004;173(2):1298-1306.
4. Hasegawa A, Miki T, Hosokawa H, etal. Impaired GATA3-dependent chromatin remodeling and Th2 cell differentiation leading to attenuated allergic airway inflammation in aging mice. J Immunol. 2006;176(4): 2546-2554.
5. Busse PJ, Zhang TF, Srivastava K, Schofield B, Li XM. Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and-challenged mice. Clin Exp Allergy. 2007;37(9):1392-1403.
6. Carnieli DS, Yoshioka E, Silva LF, etal. Inflammation and remodeling in infantile, juvenile, and adult allergic sensitized mice. Pediatr Pulmonol. 2011;46(7):650-665.
7. Hanania NA, King MJ, Braman SS, etal. Asthma in Elderly workshop participants. Asthma in the elderly: Current understanding and future research needs-a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol.2011;128(Suppl 3):S4-S24.
8. Illi S, von Mutius E, Lau S, etal. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet. 2006;368(9537):763-770.
9. Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res. 2006;7:73.
10. Gwilt CR, Donnelly LE, Rogers DF. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther. 2007;115(2):208-222.
11. Ohta S, Oda N, Yokoe T, etal. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy. 2010;40(8):1266-1275.
12. Kang JY, Rhee CK, Kim JS, etal. Effect of tiotropium bromide on airway remodeling in a chronic asthma model. Ann Allergy Asthma Immunol. 2012;109(1):29-35.
13. Restrepo RD. Use of inhaled anticholinergic agents in obstructive airway disease. Respir Care. 2007;52(7):833-851.
14. Vincken W, van Noord JA, Greefhorst AP, etal. Improved health outcomes in patients with COPD during 1yr's treatment with tiotropium. Eur Respir J. 2002;19(2):209-216.
15. Anzueto A, Tashkin D, Menjoge S, Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther. 2005;18(2):75-81.
16. Kerstjens HA, Engel M, Dahl R, etal. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012; 367(13):1198-1207.
17. Kerstjens HA, Disse B, Schroder-Babo W, etal. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol. 2011;128(2):308-314.
18. Nam HS, Lee SY, Kim SJ, etal. The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma. Yonsei Med J. 2009;50(4):569-575.
19. Myou S, Leff AR, Myo S, etal. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med. 2003;198(10): 1573-1582.
20. Padrid P, Snook S, Finucane T, etal. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med. 1995;151(1):184-193.
21. Busse PJ, Schofield B, Birmingham N, etal. The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice. Ann Allergy Asthma Immunol. 2010;104(3):236-246.
22. Kita H. Eosinophils: multifunctional and distinctive properties. Int Arch Allergy Immunol. 2013;161 Suppl 2:3-9. doi: 10.1159/ 000350662. Epub May 29, 2013.
23. Coleman JM, Naik C, Holguin F, etal. Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset. Thorax. 2012;67(12):1061-1066.
24. Chakir J, Shannon J, Molet S, etal. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol. 2003;111(6):1293-1298.
25. Agache I, Ciobanu C, Agache C, Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med. 2010;104(8): 1131-1137.
26. Silverpil E, Lindén A. IL-17in human asthma. Expert Rev Respir Med. 2012;6(2):173-186.
27. Alvarez-Rodríguez L, López-Hoyos M, Muñoz-Cacho P, Martínez-Taboada VM. Aging is associated with circulating cytokine dysregulation. Cell Immunol. 2012;273(2):124-132.
28. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161(5):1720-1745.
29. Boulet LP, Sterk PJ. Airway remodelling: the future. Eur Respir J. 2007;30(5):831-834.
30. Kistemaker LE, Oenema TA, Meurs H, Gosens R. Regulation of airway inflammation and remodeling by muscarinic receptors: Perspectives on anticholinergic therapy in asthma and COPD. Life Sci. 2012;91(21-22):1126-1133.
31. Meurs H, Dekkers BG, Maarsingh H, Halayko AJ, Zaagsma J, Gosens R. Muscarinic receptors on airway mesenchymal cells: Novel findings for an ancient target. Pulm Pharmacol Ther. 2013;26(1): 145-155.
32. Grainge CL, Lau LC, Ward JA, etal. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med. 2011;364(21): 2006-2015.
33. Lee HK, Lim MY, Bok SM, etal. Age differences in cholinergic airway responsiveness in relation with muscarinic receptor subtypes. Life Sci. 2007;81(3):204-209.
34. Wright DB, Trian T, Siddiqui S, etal. Phenotype modulation of airway smooth muscle in asthma. Pulm Pharmacol Ther. 2013;26(1):42-49.
35. Ladislas R. Cellular and molecular mechanisms of aging and age related diseases. Pathol Oncol Res. 2000;6(1):3-9.